IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.
Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy.
Hematol Oncol. 2023 Jun;41 Suppl 1:82-87. doi: 10.1002/hon.3142.
The treatment of peripheral T-cell lymphomas is challenging, as they often display a severe prognosis and lack effective treatment strategies. We will try to answer three burning questions: can we differentiate the initial treatment based on the histotype and the clinical presentation of peripheral T-cell lymphoma patients? Do we require an autologous stem cell transplantation in all patients? Is there room for improvement in the setting of relapsed and refractory disease?
外周 T 细胞淋巴瘤的治疗具有挑战性,因为它们通常预后较差,缺乏有效的治疗策略。我们将尝试回答三个热点问题:能否根据外周 T 细胞淋巴瘤患者的组织类型和临床表现来区分初始治疗?所有患者都需要进行自体干细胞移植吗?在复发和难治性疾病的情况下是否有改进的空间?